Liquidia Corporation (LQDA)

NCM – Real vaqt narxi. Valyuta: USD

78.17

+1.25 (1.63%)

Yopilishda: Jun 26, 2026, 4:00 PM EDT

77.87

-0.30 (-0.38%)

Bozordan keyin: Jun 26, 2026, 7:51 PM EDT

16.06.2026

Liquidia Corporation (LQDA) Shareholder/Analyst Call Prepared Remarks Transcript

11.06.2026

Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions

MORRISVILLE, N.C., June 11, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, announced today that the company will present four posters at the PHA 2026 International PH Conference and Scientific Sessions taking place June 11-14 in Dallas.

08.06.2026

Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index

MORRISVILLE, N.C., June 08, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, announced today that it will be added to the S&P SmallCap 600® Index, effective prior to the opening of trading on June 22, 2026.

05.06.2026

4 Best Low-Beta Stocks to Buy Right Away: LQDA, CVX, OXY & VLO

Fragile Iran ceasefire keeps stocks volatile. Low-beta picks LQDA, CVX, OXY and VLO show recent gains and solid volume.

05.06.2026

4 Biotech Stocks Investors Should Watch in 2026

New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and solid pipeline progress position LQDA, IMNM, STOK and IMCR well in this volatile sector.

28.05.2026

Are You Looking for a Top Momentum Pick? Why Liquidia Corporation (LQDA) is a Great Choice

Does Liquidia Corporation (LQDA) have what it takes to be a top stock pick for momentum investors? Let's find out.

27.05.2026

Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference

MORRISVILLE, N.C., May 27, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA) today announced that Dr. Roger Jeffs, Chief Executive Officer, and Michael Kaseta, Chief Operating Officer and Chief Financial Officer, will provide an update on the company's business in a fireside chat at the Jefferies Global Healthcare Conference in New York on Wednesday, June 3, 2026, at 12:45 p.m.

Videolar

No Data

There is no data to display

Press-relizlar

11.06.2026

Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions

08.06.2026

Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index

11.05.2026

Liquidia Corporation Reports First Quarter 2026 Financial Results

YUTREPIA® (treprostinil) inhalation powder net product sales of approximately $130 million in the first quarter of 2026 More than 4,500 unique patient prescriptions and approximately 3,750 patients treated between launch in June 2025 and April 30, 2026 Recorded third consecutive quarter of profitability, with net income of approximately $53 million, adjusted EBITDA of $71 million and an increase in cash and cash equivalents by $32 million compared to the fourth quarter of 2025 Actively screening PH-ILD patients in Phase 4 Tyvaso® and Tyvaso DPI® transition study and pivotal Phase 3 Re-Spire study of L606 MORRISVILLE, N.C., May 11, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, today reported financial results for the first quarter ended March 31, 2026.

05.03.2026

Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

MORRISVILLE, N.C., March 05, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, today reported financial results for the full year ended December 31, 2025. The company will also host a webcast at 8:30 a.m. ET on March 5, 2026, to discuss its financial results and provide a corporate update.

Liquidia Corporation (LQDA)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Liquidia Corporation (LQDA)

Liquidia Corporation (LQDA) Shareholder/Analyst Call Prepared Remarks Transcript

Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions

Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index

4 Best Low-Beta Stocks to Buy Right Away: LQDA, CVX, OXY & VLO

4 Biotech Stocks Investors Should Watch in 2026

Are You Looking for a Top Momentum Pick? Why Liquidia Corporation (LQDA) is a Great Choice

Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference

Videolar

No Data

Press-relizlar

Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions

Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index

Liquidia Corporation Reports First Quarter 2026 Financial Results

Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Liquidia Corporation (LQDA) Shareholder/Analyst Call Prepared Remarks Transcript

Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions

Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index

4 Best Low-Beta Stocks to Buy Right Away: LQDA, CVX, OXY & VLO

4 Biotech Stocks Investors Should Watch in 2026

Are You Looking for a Top Momentum Pick? Why Liquidia Corporation (LQDA) is a Great Choice

Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference

Videolar

No Data

Press-relizlar

Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions

Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index

Liquidia Corporation Reports First Quarter 2026 Financial Results

Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Search stocks

Liquidia Corporation (LQDA)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Liquidia Corporation (LQDA)

Liquidia Corporation (LQDA) Shareholder/Analyst Call Prepared Remarks Transcript

Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions

Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index

4 Best Low-Beta Stocks to Buy Right Away: LQDA, CVX, OXY & VLO

4 Biotech Stocks Investors Should Watch in 2026

Are You Looking for a Top Momentum Pick? Why Liquidia Corporation (LQDA) is a Great Choice

Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference

Videolar

No Data

Press-relizlar

Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions

Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index

Liquidia Corporation Reports First Quarter 2026 Financial Results

Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Liquidia Corporation (LQDA) Shareholder/Analyst Call Prepared Remarks Transcript

Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions

Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index

4 Best Low-Beta Stocks to Buy Right Away: LQDA, CVX, OXY & VLO

4 Biotech Stocks Investors Should Watch in 2026

Are You Looking for a Top Momentum Pick? Why Liquidia Corporation (LQDA) is a Great Choice

Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference

Videolar

No Data

Press-relizlar

Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions

Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index

Liquidia Corporation Reports First Quarter 2026 Financial Results

Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update